Company Description
Is this an operating room or Dad's workshop? Stryker's surgical products include such instruments as drills, saws, rasps, even...
Key Stryker Financials
| Company Type | Public - NYSE: SYK Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $6,000.5 |
| 2007 Employees | 16,026 |
More Stryker Financials (11 pages)
Latest Stryker Jobs jobs by Indeed
Rankings
- #401 in FORTUNE 500
- S&P 500
- #329 in FT Global 500
Competition
Competitive Landscape for Medical Supplies and Devices
Demand is driven by population demographics and advances in medical knowledge and technology. The profitability of individual companies depends on the ability to develop superior...
Read more about Stryker's competition across multiple industries
Top Stryker Competitors
Sponsored Links
The Business DirectoryTrading Toolbox
Stryker Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | John W. Brown | Network | E-mail |
| President, CEO, and Director | Stephen P. (Steve) MacMillan | Network | E-mail |
| EVP | David J. Simpson | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Tools from our advertising partners:
Current Stryker News
- Method of forming bone with porous βtricalcium phosphate granules [U.S. Patents] (01 Jul 2008 13:21:00 EDT)
- SURGICAL SAGITTAL SAW WITH INDEXING HEAD AND TOOLLESS BLADE COUPLING ASSEMBLY FOR ACTUATING AN OSCILLATING TIP SAW BLADE AND OSCILLATING TIP SAW... [European Patents] (01 Jul 2008 13:09:00 EDT)
- Implant firms pay doctors millions: As joint replacements have increased, so have payments to surgeons. [Philadelphia Inquirer (PA)] (29 Jun 2008 04:00:00 EDT)
Latest Industry Video
-
Rx For Cheap Drugs (4:04)
07/23/07 5:20PM ET - Miller Tabak & Co. Pharmaceuticals Analyst Les Fundleyder and Bain & Company Partner Tim Van Biesen discuss patent expirations affecting U.S. drug costs.